Cell growth is controlled by a lysosomal signalling complex containing Rag small GTPases and mammalian target of rapamycin complex 1 (mTORC1) kinase. Here, we carried out a microscopy-based genome-wide human short interfering RNA screen and discovered a lysosome-localized G protein-coupled receptor (GPCR)-like protein, GPR137B, that interacts with Rag GTPases, increases Rag localization and activity, and thereby regulates mTORC1 translocation and activity. High GPR137B expression can recruit and activate mTORC1 in the absence of amino acids. Furthermore, GPR137B also regulates the dissociation of activated Rag from lysosomes, suggesting that GPR137B controls a cycle of Rag activation and dissociation from lysosomes. GPR137B-knockout cells exhibited defective autophagy and an expanded lysosome compartment, similar to Rag-knockout cells. Like zebrafish RagA mutants, GPR137B-mutant zebrafish had upregulated TFEB target gene expression and an expanded lysosome compartment in microglia. Thus, GPR137B is a GPCR-like lysosomal regulatory protein that controls dynamic Rag and mTORC1 localization and activity as well as lysosome morphology.
C ells regulate growth, autophagy and metabolism by employing a lysosomal regulatory complex consisting of heterodimers of Rag small GTPase proteins (one RagA/B protein paired with one RagC/D protein) [1] [2] [3] and the cytoplasmic regulatory complex mechanistic target of rapamycin complex 1 (mTORC1) containing the protein kinase mTOR and an adapter protein regulatory-associated protein of mTOR (raptor) 4, 5 (Fig. 1a) . Rag dimers are anchored to lysosomes and activated by a lysosome-localized Ragulator adapter complex 6, 7 , and inactivated by a GATOR1 complex that stimulates the hydrolysis of GTP in active RagA/B-GTP to produce inactive RagA/B-GDP 8, 9 . Amino acids, glucose and possibly other nutrients increase the activity of Rags and thereby recruit mTORC1 to lysosomes 4, 10, 11 . Active Rags also recruit and repress TFEB, a transcription factor that controls the expression of genes needed for lysosome biogenesis and function 12, 13 . Once localized at lysosomes, the kinase activity of mTORC1 is regulated by growth factors through a phosphatidylinositol-3-OH kinase (PI3K)-AKT-tuberin (TSC2)-Rheb signalling pathway and other mechanisms [14] [15] [16] [17] . Nevertheless, most of the known regulators of mTORC1 are not unique to lysosomes. Only two lysosomal transmembrane proteins, the proton pump v-ATPase and the arginine transporter SLC38A9, have been shown to regulate mTORC1 (refs. [18] [19] [20] [21] ), suggesting that additional lysosome-specific transmembrane proteins may regulate Rag activity.
Cells with ablated Rags have expanded lysosomes, accumulated autophagosomes and increased expression of TFEB transcriptional targets, but still retain some mTORC1 activity [22] [23] [24] [25] . Knockout of two Rag regulators, WDR24 and LAMTOR1, showed similar lysosome and autophagy defects 26, 27 . These studies uncovered essential functions of Rags in lysosome/autophagy regulation and point towards other mTORC1 regulators that remain to be identified.
Here, we used a genome-wide short interfering RNA (siRNA) screen to identify additional regulators of lysosomal mTORC1 localization and activity. We identified GPR137B, a lysosome-localized G protein-coupled receptor (GPCR)-like protein with unknown function, as a regulator that promotes the recruitment and activation of mTORC1. We show that GPR137B regulates mTORC1 through Rag proteins by (1) interacting with Rag proteins and increasing the Rag concentration at lysosomes and (2) increasing the GTP-loaded, active state of lysosomal RagA, which causes the recruitment of mTORC1 and an accelerated dissociation of active Rags from lysosomes. We further show that knockout of GPR137B in human cells results in a similar expansion of lysosome compartments and increased autophagy as observed in RagA/B-knockout mouse embryonic fibroblasts (MEFs) and cardiomyocytes 23 . We generated gpr137ba-mutant zebrafish and further observed that these animals have some phenotypic similarities to rraga (encoding RagA) mutants, including an upregulation of TFEB target genes and an expanded lysosomal compartment phenotype in microglial cells in vivo. Together, our study introduces a GPCR-like activator of lysosomal Rag and mTORC1 signalling that regulates the dynamic exchange of active Rags at lysosomes and provides a potential therapeutic target to regulate mTORC1 activity.
Results
A human siRNA screen identifies a lysosome-localized GPCR-like protein as a regulator of mTORC1. We used 21,041 pools of 4 siRNAs to identify mediators of amino acid signalling to mTORC1 in human fibroblasts (Hs68). Our microscopy-based assay monitored the amino acid-triggered increase in phosphorylation of the ribosomal protein S6 (rpS6) at residue 240 and 244 (refs. 28, 29 ) (Fig. 1a,b and Supplementary Fig. 1a ). The assay captured roughly showing that amino acid-triggered increase in mTOR localization at lysosomes is regulated by GPR137B-YFP overexpression. Error bars indicate ±s.d. of the mean; n = 8 independent experiments; P = 1.6 × 10 −13 (two-tailed Student's t-test). g, Lysosomal localization of GPR137-YFP and GPR137C-YFP (HeLa cells). h, siRNA knockdown of GPR137B enhances autophagy as measured by LC3-GFP. Error bars indicate ±s.d. of the mean; n = 3 independent experiments (two-tailed Student's t-test). i,j, siRNA knockdown of GPR137B causes autophagy flux defects as measured by p62 staining (i) and the fold change of p62 puncta number (j). Scale bar, 20 μm. Error bars indicate ±s.d. of the mean (P value was calculated by a ratio paired, two-tailed Student's t-test; n = 3 independent experiments). k, GPR137B-YFP expression causes phosphorylation of 4E-BP1 during amino acid starvation. Error bars indicate ±standard error of the mean (s.e.m.) of the mean (P values, comparison of transfected, n = 2,329 cells for no amino acids, n = 2,211 cells for plus amino acids and n = 2,308 cells for Torin; to untransfected cells, n = 3,256 cells for no amino acids, n = 3,099 cells for plus amino acids and n = 3,048 cells for Torin; two-tailed Student's t-test). l, Knockdown of GPR137B inhibits amino acid-induced S6K and 4E-EP1 phosphorylation. HEK293T cells transfected with siControl, siGPR137B or siRAGA/C were starved of amino acids for 1 h and stimulated with or without amino acids for 30 min. Western blot analysis of phosphorylation of S6K and 4E-BP1 is shown. m, Same as panel l but with transiently transfected GPR137B-3×FLAG or Lamp1-3×FLAG. Amino acid starvation occurred for 3 h and amino acid re-addition for 30 min with or without rapamycin. DMSO, dimethylsulfoxide. Results in b, c and g were confirmed by three independent experiments and by two independent experiments in l and m. In all figures, *P = 0.01-0.05; **P = 0.001-0.1, ***P < 0.001. All scale bars are 10 μm except when noted.
an equal number of 1,000 siRNA pools that target positive and negative regulators (Fig. 1c, Supplementary Fig. 1b and Supplementary  Table 1) , such as the known mTORC1 activator Rheb and the suppressor TSC2 (Fig. 1c, arrows) . We confirmed the screening results using individual siRNAs and narrowed our focus on 427 highconfidence candidates ( Supplementary Fig. 1c ). Ingenuity pathway analysis showed that genes associated with insulin-growth factor, PI3K-AKT, extracellular signal-regulated kinase (ERK)-mitogen-activated protein kinase (MAPK), Hedgehog, p53, 5′-AMPactivated protein kinase (AMPK), the glycine cleavage pathway and cell-cycle signalling pathways were significantly enriched in the set (Supplementary Fig. 1d and Supplementary Table 2) .
As amino acid-induced translocation of mTORC1 to lysosomes is a key step in the activation process 6, 8 , we used automated microscopy to monitor mTORC1 translocation by quantifying the colocalization between the lysosome marker lysosome-associated membrane glycoprotein 2 (Lamp2) and mTOR. To exclude indirect regulators that control amino acid uptake, we starved cells and then induced a transient increase in intracellular amino acids by inhibiting protein translation using cycloheximide 30 ( Fig. 1d and Supplementary Fig. 1e ). Using this assay, we screened for effects caused by the knockdown of each of the 427 candidate genes. A small subset of hits significantly reduced mTOR translocation to lysosomes as well as rpS6 phosphorylation (Fig. 1e,f) , consistent with the interpretation that only some genes regulate the translocation of mTORC1, whereas most genes regulate mTORC1 activity after lysosome translocation. Supplementary Table 3 shows a rank-ordered list of 15 identified genes. RagC was the top hit regulating mTOR translocation in the screen, followed by less-characterized candidate genes that include transporters, the anti-apoptotic factor TIAF1 and a F-box DNA helicase, suggesting that mTORC1 translocation is regulated by nutrient, metabolism and stress pathways. We focused our subsequent analysis on GPR137B, because it is localized to the lysosome 31 and because it is a predicted seven-transmembrane protein with a low sequence homology to GPCRs (Fig. 2a) . +/+ (control (CNTRL)) and Rraga/b −/− MEFs either stably expressing GPR137B or not stably expressing GPR137B. Error bars are ±s.d. of the population average and one-way ANOVA analysis followed by Tukey's test shows that there is significance among control groups with or without GPR137B, but not among Rraga/b −/− MEFs with or without GPR137B; n = 4 independent experiments. d, Expression of the constitutively active RagA/C heterodimer (RagA Q66L/RagC T75N) rescued mTOR translocation in cells treated with siGPR137B. The left panel shows HeLa cells transfected with siGPR137B and RagA Q66L/RagC T75N (YFP-RagA/C CA) and then stained for mTOR. Cells co-expressing YFP-RagA/C CA are marked by blue dashed lines. The right panel shows an analysis of the effects on mTOR translocation by Lamp1-GFP or YFP-RagA/C CA expression in cells treated with siGPR137B versus siControl. Error bars are ±s.d. of the population average and the P value was calculated using a two-tailed Student's t-test; n = 4 independent experiments Scale bars, 20 μm. Cyto, cytoplasm. fl, fluorescence. e, GPR137B does not induce additional mTOR translocation in NPRL3 −/− HEK293E cells that have constitutively active RagA. Parental HEK293E cells or NPRL3 −/− cells transfected with either Lamp1-Turquoise (Turq) or GPR137B-Turquoise were treated as in a. The mean from n = 2 independent experiments is plotted. *P < 0.05; ***P < 0.001.
GPR137B regulates lysosomal localization and activity of mTORC1. Consistent with a reported lysosomal localization 31 , we found that GPR137B-yellow fluorescent protein (YFP) colocalized with the lysosomal marker Lamp2 and with mTOR after amino acid stimulation (Fig. 2b) . We quantified the relative lysosomal localization of mTOR using a colocalization score or automated analysis of mTOR localization based on a binary lysosome mask (Supplementary Note). Independent siRNAs in two cell types (Hs68 and HeLa cells) confirmed the screening result (Fig. 2c,d and Supplementary Fig. 2a-c) . Time-course analysis of rpS6 phosphorylation revealed that GPR137B knockdown reduces basal mTORC1 activity in nutrient-replete cells as well as mTORC1 reactivation in nutrient-stimulated cells (Supplementary Fig. 2d ). Furthermore, overexpression of GPR137B increased mTOR translocation weakly in the presence of amino acids and strongly in the absence of amino acids (Fig. 2e,f and Supplementary Fig. 2e ). Finally, GPR137 and GPR137C, two genes homologous to GPR137B, probably have a similar role in regulating mTORC1 as we found that they were also localized to the lysosome (Fig. 2g) and both increased mTOR translocation to lysosomes when overexpressed ( Supplementary  Fig. 2f,g ). Together, these results suggest that GPR137B is part of a family of lysosome-localized GPCR-like proteins that regulate mTORC1 translocation to lysosomes.
An important role of mTORC1 is to inhibit autophagosome formation through phosphorylation of the ULK1-mATG13-FIP200 complex 32 . Consistent with a role of GPR137B in regulating mTORC1 activity, knocking down GPR137B increased autophagy, as indicated by an increase in the number of LC3-GFP puncta per cell (Fig. 2h) . p62 (also known as SQSTM1) is an ubiquitin-binding protein that is degraded by autophagy and accumulates if autophagy flux is reduced or defective 10, 23, 25, 27, 33 . We observed a marked upregulation of p62 in GPR137B-knockdown cells, and the larger, brighter p62 and LC3-GFP puncta observed mostly in GPR137B-depleted cells colocalized with each other (Fig. 2i,j) , suggesting that autophagy flux defects contribute to the LC3 phenotype in GPR137B-knockdown cells.
The translational regulators eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1) and S6 kinase (S6K) are critical mTORC1 substrates and regulators of protein synthesis and cell size [34] [35] [36] . Overexpression of GPR137B-YFP in cells starved of amino acids increased the phosphorylation of 4E-BP1 close to the level reached by amino acid stimulation ( Fig. 2k and Supplementary  Fig. 2h for controls) . Furthermore, biochemical analysis confirmed that knockdown of GPR137B suppresses the phosphorylation of S6K and 4E-BP1 (Fig. 2l) , and the GPR137B expression-mediated increase in S6K and 4E-BP1 phosphorylation was abolished following rapamycin treatment (Fig. 2m) . Finally, GPR137B mediates its effects on S6K through amino acid signalling rather than growth factor regulation of mTORC1 ( Supplementary Fig. 2i,j) . Thus, GPR137B regulates amino acid-induced mTORC1 translocation to lysosomes and mTORC1 activity, and probably has a functional role in regulating autophagy as well as protein synthesis and cell size through the regulation of S6K, 4E-BP1 and other mTORC1 targets.
GPR137B regulates mTORC1 localization and activity through Rag GTPases. Several lines of evidence argue that GPR137B regulates mTORC1 localization and activity through Rags. First, we used RagA/B-knockout MEFs 23 and found that stable expression of GPR137B in these cells could not restore mTORC1 translocation (Fig. 3a-c and Supplementary Fig. 3a) . Second, when we overexpressed constitutively active RagA/C (RagA Q66L and RagC T75N) 4 in HeLa cells, knockdown of GPR137B did not alter the increased lysosomal mTORC1 localization (Fig. 3d) . In an independent strategy to activate endogenous Rags, we overexpressed GPR137B in HEK293E cells deficient for the GATOR1 component NPRL3 (refs. 8, 37 ) that have constitutively active RagA. Whereas the wild-type cells showed a GPR137B expression-mediated increase in mTORC1 translocation, GPR137B did not cause additional mTORC1 translocation in the knockout cells (Fig. 3e) . Together, these results suggest that GPR137B signals through Rag GTPases to regulate mTORC1 translocation and activity.
GPR137B interacts with Rags and increases the lysosomal localization of RagA. We next evaluated the binding interactions of GPR137B with known components of the mTORC1 regulatory machinery. In HEK293T cells, we found that GPR137B co-immunoprecipitated with mTOR, raptor and RagA ( Fig. 4a and Supplementary Fig. 3b) . Control experiments using the unrelated lysosomal transmembrane protein NPC intracellular cholesterol transporter 1 (NPC1) as well as tests using other mTORC1 regulators are shown in Supplementary Fig. 4a,b .
Interestingly, when we co-expressed two GPR137B constructs with different tags, we observed an apparent amino acid-stimulated interaction of GPR137B with itself that is dependent on the presence of Rags (Fig. 4b) , suggesting that more than one GPR137B protein is part of an amino acid-regulated lysosomal signalling complex. Experiments using RagA/B-knockout MEFs suggest that this amino acid-regulated self-interaction of GPR137B proteins does not require Rag activity, suggesting a possible direct or indirect regulation of GPR137B by amino acids ( Fig. 4c and Supplementary  Fig. 4c ). Notably, the interaction between GPR137B and RagA was not amino acid sensitive ( Fig. 4a and Supplementary Fig. 4d ).
It has recently been reported that Sestrin2 functions as a leucine sensor [37] [38] [39] [40] [41] . We used Sestrin1/2/3 triple-knockout cells 37 that have increased basal lysosomal localization of mTORC1. However, overexpression of GPR137B could further increase mTOR translocation to lysosomes in these cells ( Supplementary Fig. 4e ), arguing that GPR137B can regulate Rag and mTORC1 independent of the Sestrins. Thus, we did not further investigate this regulatory pathway.
We next tested whether GPR137B regulates the localization of Rags analogous to Ragulator proteins that anchor Rags to lysosomes. Markedly, increased GPR137B expression did not only increase mTOR translocation but also caused a small but significant increase in RagA localization at lysosomes ( Fig. 4d ; see Supplementary Fig. 4f for RagC data), whereas siRNA against GPR137B reduced lysosomal RagA (Fig. 4e) and RagC (Fig. 4f) localization. Knockdown of the Ragulator component LAMTOR2 is included for comparison. When Ragulator expression was reduced, GPR137B did not significantly increase Rag recruitment or mTORC1 activity, and co-expressing GPR137B did not rescue the reduced RagA lysosomal localization ( Supplementary  Fig. 4g,h ). Thus, GPR137B interacts with Rags and increases lysosomal Rag localization in a Ragulator-dependent manner. Taken together with our data in Fig. 3 , the binding and localization results suggest that GPR137B regulates Rag localization and possibly RagA-GTP loading and activity.
GPR137B increases Rag activity to recruit mTORC1. We used the selective binding of mTORC1 to RagA-GTP over RagA-GDP as a measure to determine whether RagA is in the active GTPbound state 4 . Consistent with a role of GPR137B in regulating RagA-GTP loading, knockdown of GPR137B inhibits the amino acid-induced interaction between RagA and both mTOR and raptor ( Fig. 5a and Supplementary Fig. 5a,b) , whereas overexpression of GPR137B increases the interaction between them ( Fig. 5b and Supplementary Fig. 5c,d) . Markedly, at high GPR137B expression levels, the binding of RagA and raptor is increased even in the absence of amino acids, suggesting that overexpression of GPR137B can increase RagA-GTP loading even in the absence of amino acids ( Fig. 5b and Supplementary Fig. 5c,d) .
We next determined whether co-expression of Rag and GPR137B induces synergistic mTORC1 translocation. When we co-expressed Fig. 4 | GPR137B forms an amino acid-sensitive complex with mTORC1 through Rag GTPases and binds to RagA constitutively as an adaptor for lysosomal localization. a, Amino acid-regulated interaction of GPR137B with mTOR, raptor and RagA. HEK293T cells were stably expressing Lamp1-3×FLAG or GPR137B-3×FLAG, starved of amino acids for 2 h and stimulated for 10 min. IP, immunoprecipitation. b, Rag GTPases are necessary for the GPR137B-mTOR interaction, and evidence of self-interaction between GPR137Bs is shown. GPR137B-3×FLAG and GPR137B-HA were stably expressed in control or Rraga/b
MEFs. c, RagA overexpression restores GPR137B self-interaction regardless of RagA-GTP loading. RagA DN(T21N), wild type (WT) or CA(Q66L) mutants were expressed in Rraga/b −/− MEFs. Cells were amino acid starved for 4 h then stimulated for 20 min. For a-c, n = 2 independent experiments. d, Amino acid (aa) stimulation reduces lysosomal localization of RagA, and GPR137B increases RagA localization at lysosomes. Increasing the expression of GPR137B causes a gradual increase in the lysosomal localization of mTOR (left panels), as well as of RagA (right panels). Amino acid-starved or restimulated HeLa cells expressing either Lamp1-Turquoise or GPR137B-Turquoise were stained for endogenous mTOR or RagA and Lamp2 and binned for different levels of Turquoise expression. The median value for each bin is plotted as the mean of triplicates ± s.d. from three independent experiments. Repeated-measures oneway ANOVA analysis followed by Tukey's test shows significant differences among different expression bins of GPR137B but not of Lamp1. e,f, Knockdown of GPR137B decreases lysosomal localization of RagA (e) and of RagC (f) in amino acid-starved and restimulated HeLa cells. Two-tailed, Student's t-test shows significant difference between control and siGPR137B; **P < 0.01 and ***P < 0.001. Mean ± s.d. is plotted from n = 3 independent experiments. −/− MEFs transiently expressing either Lamp1 as control or GPR137B, along with wild-type or DN RagA/C proteins, were starved for 2 h, fixed and stained for mTOR and Lamp2. In c-e, RagC expression is used as a readout of RagA/C dimer expression.
RagC
42 together with Lamp1 control, mTORC1 translocation did not significantly increase, suggesting that Rags, at any level, mediate only minimal basal mTORC1 recruitment when amino acids are low (Fig. 5c,d ). By contrast, we found synergistic recruitment of mTORC1 when we co-expressed Rag together with GPR137B ( Fig. 5c , right panel, Fig. 5d , blue line, and Supplementary Fig. 6a ). The strong synergy between GPR137B and Rag expression on mTOR translocation is consistent with a direct regulation of Rags by GPR137B.
To further investigate whether GPR137B causes mTORC1 translocation through promoting Rag-GTP loading, we coexpressed GPR137B with wild-type or dominant negative (DN) RagA/C (RagA T21L/RagC Q120L) in Rraga/b-null MEFs. These RagA/B-knockout cells had no mTORC1 translocation when stably expressing GPR137B alone (Fig. 3b,c) , and minimal rescue of mTORC1 translocation when transiently co-expressing wildtype or DN RagA/C and Lamp1. By contrast, we observed robust mTORC1 translocation even in the absence of amino acids when we co-expressed GPR137B and wild-type RagA/C, but significantly lower translocation when we co-expressed DN RagA/C (Fig. 5e and Supplementary Fig. 6b-d) . These results support the hypothesis that the level of GPR137B regulates RagA-GTP loading and activity.
Photobleaching recovery analysis suggests that GPR137B regulates a cycle of dynamic activation and dissociation of lysosomal Rags. Figure 4d also revealed an unexpected amino acid-triggered reduction in Rag localization at lysosomes. When we compared the kinetics of Rag and mTOR localization, we found that endogenous RagA and RagC dissociated from lysosomes in response to amino acids with kinetics that paralleled the increase in mTOR translocation to lysosomes (Fig. 6a-c) . We next made use of previous studies that showed a negative feedback in which mTORC1-mediated Rag ubiquitylation reduces lysosomal localization of mTORC1 after amino acid stimulation 43, 44 . Indeed, when we treated amino acidstimulated cells with rapamycin to inhibit the activity of mTORC1, more mTOR translocated to lysosomes and a greater fraction of RagA and RagC dissociated from lysosomes ( Fig. 6d-f) . The anticorrelated kinetics and amplitude of mTOR and Rag localization suggest that the recruitment of mTORC1 and the dissociation of Rags are connected events.
We next used fluorescence photobleaching recovery analysis to test whether GTP loading of RagA accelerates dissociation of RagA/C from lysosomes. In cells overexpressing fluorescently tagged wild-type RagC and DN RagA, the RagC dissociation rate was slower than in cells co-expressing wild-type RagC and constitutively active (CA) RagA (Fig. 6g,h ). This suggests that GTP loading of RagA lowers the affinity of RagA/C for lysosomes and accelerates RagA/C dissociation. Indeed, lysosomal RagC dissociated more rapidly after amino acid stimulation, which increased GTP loading of RagA (Fig. 6i) . These results are consistent with a recent publication showing Rags cycle on and off the lysosomes depending on their activation state 45 . When we expressed GPR137B in amino acid-starved cells, we found a small but significant increase in RagC dissociation (Fig. 6j,k) . Conversely, when we knocked down GPR137B, there was a small but significant decrease in the RagC exchange rate (Fig. 6l,m) . When we expressed GPR137B in NPRL3 −/− HEK293E cells where Rags are mostly GTP loaded 8 , there was no significant difference in the RagC exchange rate from control cells ( Supplementary Fig. 6e,f) . Taken together, these results suggest that GPR137B accelerates Rag dissociation from the lysosome through RagA-GTP loading.
Together with previous studies that showed mTORC1 can be active at different cellular locations 46, 47 , these results suggest that GPR137B regulates Rags in three steps: first, by increasing RagA levels at the lysosomes; second, by promoting the activation of lysosomal RagA, which recruits mTORC1 to the lysosomes for a limited time period; and third, by promoting Rag dissociation from the lysosomes possibly as an active or activatable cytosolic RagmTORC1 complex.
To directly test whether RagC and the mTORC1 subunit raptor can remain bound to each other in the cytoplasm, we co-expressed RagC with a conjugated C1 domain from rat protein kinase C-γ (PKC-γ) 48 along with fluorescently tagged raptor, CA RagA and a membrane marker in HEK293T cells. In this in vivo binding assay, a phorbolester (phorbol myristate acetate (PMA)) was used to rapidly recruit cytosolic C1-conjugated RagC to the plasma membrane and monitor how much of the putative binding partner raptor is pulled along. Indeed, we observed a concomitant recruitment of raptor (Fig. 7a-c and Supplementary Fig. 7a,b) , arguing that Rags and the mTORC1 subunit raptor can be bound to each other in the cytoplasm. Given the finding that inactive Rags do not bind to raptor 4, 49 , and active Rag dissociates from the lysosomes along with mTOR 45 , our results suggest that active Rag-mTORC1 complexes diffuse in the cytoplasm after dissociation and that Rag-mTORC1 remains in an active state until Rag is inactivated.
Mutational analysis in human cells and zebrafish provides evidence that GPR137B regulates lysosomal morphology through Rag. Both GPR137B-knockout and GPR137-knockout HAP1 cells showed an expanded lysosomal compartment as measured by larger LysoTracker green-positive puncta (Fig. 8a,b) , as well as an increased number of autophagosomes and/or autolysosomes as measured by increased LC3B puncta per cell (Fig. 8c ), similar to Rag or Rag regulator knockouts 23, 26, 27 . In addition, in both cell lines, the lysosomal localization of endogenous RagA was decreased, similar to the GPR137B knockdown result (Fig. 8e) . Nevertheless, mTORC1 translocation to lysosomes was still regulated by amino acids in both knockout cell lines ( Fig. 8d and Supplementary Fig. 8a) .
To investigate the function of GPR137B in vivo, we focused on four homologues of GPR137B in zebrafish: gpr137ba, gpr137bb, gpr137c and gpr137. Of these, Gpr137ba is most similar to the human GPR137B protein ( Supplementary Fig. 8b,c) . The hypothesis that GPR137B activates RagA predicts that there should be phenotypic similarities between rraga mutants and mutants in one or more of the four gpr137 genes. We generated mutants for three of the annotated genes, gpr137ba, gpr137c and gpr137, using transcription activator-like effector nuclease (TALEN)-targeting nucleases ( Supplementary Fig. 8d ). gpr137bb was annotated more recently and we have analysed its function in transient clustered regularly interspaced short palindromic repeats (CRISPR) experiments. Our preliminary studies revealed similarities between mutants for rraga and gpr137ba, but not gpr137c or gpr137 mutants, or wild-type fish injected with CRISPR-associated protein 9 (Cas9) and guide RNA for gpr137bb. Thus, we focused additional analyses on the gpr137ba mutants.
Zebrafish rraga mutants have abnormal microglia with expanded lysosomes 25 , so we examined these specialized brain macrophages in gpr137ba-mutant zebrafish. Microglia in gpr137ba mutants had an expansion of the lysosomal compartment, with large clusters of LysoTracker red-positive puncta, similar to rraga-mutant zebrafish (Fig. 8h,i) . Homozygous gpr137ba-mutant fish had otherwise normal morphology and were viable as adults ( Supplementary Fig. 8e ). Microglial cell numbers and markers of autophagy, such as LC3B and p62, were unchanged in gpr137ba mutants relative to controls (Fig. 8f,g and Supplementary Fig. 8f ).
RagA represses the activity of the key lysosomal transcription factor TFEB 50 , and quantitative real-time PCR studies in zebrafish have demonstrated that transcripts of some TFEB targets are significantly upregulated in rraga-mutant zebrafish 25, 51 . The hypothesis that GPR137B activates RagA predicts that TFEB targets will be similarly upregulated in gpr137ba mutants. To investigate this possibility, we conducted quantitative real-time PCR on larvae from a cross of gpr137c
+/− adults. Individual fish were genotyped for the gpr137ba mutation and pooled, so that one pool of siblings was gpr137ba −/− , whereas the other pool was gpr137ba +/− ; mutations in the other genes were randomly segregated between both pools. Quantitative PCR analysis revealed that some TFEB target genes were significantly upregulated in the gpr137ba-mutant pool compared to the control pool (Fig. 8j) , providing evidence that gpr137ba, similar to rraga, represses the activity of TFEB. Although the levels of p62 protein were similar in immunoblot analysis ( Supplementary  Fig. 8f ), p62 (sqstm1) is one of the TFEB target genes whose expression was upregulated in the gpr137ba-mutant pool (Fig. 8j) . In summary, this analysis revealed some phenotypic similarities between zebrafish mutants for gpr137ba and rraga, providing evidence that GPR137B regulates the activity of RagA and, as a consequence, the expression of TFEB targets. Together, the cellular effects of these knockouts indicate that GPR137B also regulates some aspects of Rag function in vivo.
Discussion
Our genome-wide siRNA screen identified GPR137B as a regulator of mTORC1 activation and localization. We focused on GPR137B in part because of its homology to GPCRs, as GPCRs are among the most prominent drug targets in clinical use and because mTORC1 and other lysosomal regulatory pathway components have emerged as promising therapeutic targets for cancer and other diseases 52 . GPR137B has two human homologues that we show also localize to lysosomes and regulate mTORC1 translocation ( Fig. 2g and Supplementary Fig. 2f,g ). When we performed a sequence homology analysis across multiple eukaryotes 53 , we found that genes in the GPR137 family have roots in early eukaryotes, with GPR137B homologues being present in Dictyostelium discoideum, Monosiga Bervicollis, many invertebrates and all vertebrates ( Supplementary  Fig. 8g) . Notably, the mTORC1 regulators Rag, Ragulator and GPR137s all have ancient roots, but Ragulator and GPR137s can each individually or both be lost in different evolutionary branches, suggesting that different species may use alternative control mechanisms to regulate Rags and mTORC1.
Our study shows that knockdown and added expression of GPR137B reduces and increases, respectively, amino acid-triggered mTORC1 translocation to lysosomes and mTORC1 activity. Furthermore, increased expression of GPR137B can activate mTORC1 even under amino acid-starved conditions (Fig. 2f) . We provide different lines of evidence that GPR137B regulates mTORC1 through regulation of both the localization and the activity of Rags. First, GPR137B no longer regulates mTORC1 lysosomal localization in RagA/B-knockout cells (Fig. 3b,c) . Second, the binding interaction between RagA-GTP and mTORC1 shows that GPR137B regulates the GTP-loading state of RagA (Fig. 5a,b) . Third, we show that GPR137B interacts with RagA and increases Rag recruitment to lysosomes (Fig. 4d) . We also showed synergistic control of mTORC1 translocation by GPR137B and Rags in amino acid-starved cells, where mTORC1 recruitment increases in parallel with increasing concentrations of both Rags and GPR137B (Fig. 5c-e and Supplementary Fig. 6b ) and significant reduction in mTORC1 translocation when DN Rags are co-expressed, suggesting that GPR137B regulates RagA-GTP loading without additional rate-limiting factors.
Our study further revealed that, in response to amino acid stimulation, RagA and RagC dissociate faster from lysosomes along with mTORC1 as a result of RagA-GTP loading (Fig. 6) . In support of such a model, we further show that Rags and raptor remain bound to each other while freely diffusing in the cytoplasm (Fig. 7) . This is consistent with the interpretation that GPR137B regulates the formation of active Rag-mTORC1 complexes at lysosomes in an activation cycle in which the activated Rag-mTORC1 complexes later dissociate from the lysosomes to potentially activate substrates elsewhere in the cell until Rag is inactivated. Only low YFP-raptor-expressing cells were analysed. n = 3 independent experiments; data represent mean ± s.d.; the P value was calculated from a two-tailed Student's t-test; ***P < 0.001.
We investigated knockouts of GPR137B in human HAP1 cells and in developing zebrafish. Previous studies of RagA/B knockouts in mouse and fish showed that cells can compensate and regulate mTORC1 signalling in a lysosome-independent manner when they lose Rags 22, 23, 25 . However, knockouts of Rags and Rag regulators 23, [25] [26] [27] showed a marked increase in accumulation of autophagosomes and/or autolysosomes as well as lysosomal compartment expansion. Similar to Rag-mutant cells, our study showed that No amino acids Plus amino acids P a r e n t a l G P R 1 3 7 G P R 1 3 knockout of GPR137B, or of GPR137, caused an increase in the number of LC3B-positive puncta as well as enlarged lysosomal compartments in human cells (Fig. 8a-c) . Furthermore, similar to RagA-mutant fish, lysosomes were expanded in the microglia of gpr137ba zebrafish mutants (Fig. 8h,i) , and targets of the lysosomal transcription factor TFEB, which is repressed by RagA, are upregulated in gpr137ba-mutant zebrafish (Fig. 8j) . Together, these results suggest that GPR137B knockout has overlapping cellular and physiological effects with knockouts of RagA/B and of two Rag regulators, consistent with the interpretation that GPR137B has a cellular and organismal function to regulate Rags.
Finally, GPR137B is, to our knowledge, unique in that its expression can increase both Rag and mTORC1 localization to lysosomes even in the absence of amino acids, and can regulate a dynamic cycle of RagA activation and lysosome dissociation. Given the key roles of mTORC1 signalling in many cancers, it is interesting that a few reports, without providing molecular mechanisms, have suggested a link between GPR137 and GPR137B and different types of cancers [54] [55] [56] [57] . Together with our mechanistic results on the role of GPR137B in Rag and mTORC1 regulation, this suggests that the three human GPCR-like GPR137 genes are potential therapeutic targets for cancers that depend on RagA and/or mTORC1 signalling for growth and survival.
Online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of code and data availability and associated accession codes are available at https://doi.org/10.1038/ s41556-019-0321-6. Immunofluorescence. Cells were fixed in 4% formaldehyde in PBS for 30 min at room temperature, washed with PBS followed by 15 min of 0.2% Triton X-100 permeabilization on ice. BSA (3%) in 1× PBS was used for blocking for 30 min at room temperature. Primary antibodies were added overnight at 4 °C (Hoechst and fluorescent secondary antibodies were added after washing for 1-2 h at room temperature). Images were taken either with a ×20 air objective on an automated inverted epifluorescence microscope (ImageXpressMicro, Molecular Devices) or with a ×40 or ×100 oil objective on a confocal microscope (Leica TCS SP2 AOBS or 3i imaging system). See the section 'Fixed/live-cell imaging' for a more detailed description; see Supplementary Table 5 for antibody information.
Zebrafish lines and maintenance. The Tupfel long-fin (TL) strain of Danio rerio was used for all zebrafish experiments. All work with zebrafish was conducted with approval from the Stanford University Institutional Animal Care and Use Committee. Embryos and larvae were treated with 0.003% 1-phenyl-2-thiourea (PTU) to inhibit pigmentation and anaesthetized with 0.016% (w/v) tricaine prior to experimental procedures.
Genome-wide siRNA screen and hit selection. The primary screen was performed using human primary foreskin fibroblasts (Hs68 cells). Serum was removed to maximize the amino acid-induced signal. Cells were stimulated after amino acid removal with a 1× mixture of all amino acids without glutamine (Fig. 1b, schematic ). An siARRAY whole human genome siRNA library from Thermo Fisher Scientific (formerly Dharmacon; G-005000-025), containing 21,041 siRNA pools in 267 × 96-well plates, 80 siRNA pools per plate, was screened using a 384-well formatted assay. Three replicates of each mother siRNA plate were tested at 10 nM concentration in the primary screen; a total of 204 384-well plates. All transfections were done using a Vprep (Velocity 11) with a 96-tip disposable tip head. Lipofectamine 2000 addition and cell addition were done with a Wellmate Dispenser (Matrix). All washing steps, including serum starvation and amino acid starvation were done using the Plate Washer (Bio-TEK). Hs68 cells were reverse transfected and the transfection mix was removed 18-24 h later. Cells were then serum starved with DMEM/0.1% BSA to keep cell numbers consistent among wells. Post-transfection (68-72 h), cells were amino acid starved in 1.5% BSA/DPBS for 3 h and restimulated with an amino acid mixture (1× amino acid) prepared from diluting 50× essential amino acids and 100× non-essential amino acids in 1.5% BSA/DPBS. Cells were fixed and stained with an antibody against rpS6 phosphorylated at 240/244. Phosphorylation of rpS6 was imaged with an automated microscope (Axon, Molecular Devices), and integrated fluorescence intensity was quantified using CellProfiler 58 .
Primary screen analysis. Using automated fluorescence imaging and automated analysis of antibody staining, we averaged the integrated single-cell rpS6 phosphorylation intensities across all cells in a single well. The mean rpS6 phosphorylation intensity for each well was calculated as the deviation from the median of the surrounding 20 wells in the 384-well plate, to minimize regional plate artefacts. The standard deviations (s.d.) of the three replicates of each siRNA treatment (each plate was assayed in parallel in triplicate) were used as a measure of experimental variability 59, 60 . The region-corrected means were normalized to the average of the triplicate s.d. for the entire plate to generate a Z-score = (X-μ)/σ. The parameter μ was estimated using the regional median and the σ parameters were estimated using replicates in each triplicate set. A comparison to nearby 20 wells was used as the library is not randomly organized. Z-scores were normalized to the median Z-score of positive controls (RHEB siRNA (siRHEB) or siTSC2 controls) in each triplicate set. The resulting fold-change values were used to create a rankordered list of genes and the top 750 genes were selected as hits. An additional list of hits (with a minimum Z-score of 2) was selected based on an additional criterion of matching functional identifiers or literature data (for example, kinase and exchange factor). With these added hits, a total of 1,231 genes were selected for further analysis.
Deconvolution of siRNA pools. Using the same assay as in the primary screen, each single siRNA of the 1,231 selected pools was tested separately again in a 384-well formatted assay (4 siRNAs targeting the same gene in each pool). Each siRNA was transfected at 10 nM concentration. A quadrant of each plate was filled with siRNA targeting a scrambled sequence (negative controls). The mean integrated phospho-rpS6 intensity for each well was region corrected by subtracting the average of the mean phospho-rpS6 intensities of the negative controls in a 22-well neighbourhood, and then divided by the s.d. of the mean phospho-rpS6 intensities of all of the negative control wells on the same plate. The generated Z-scores were then averaged across duplicates. For each of the original 1,231 pools, the deconvolution score was calculated as the average of the second and third strongest single siRNAs. We averaged the second and third strongest siRNA as we noticed a tight correlation between the first siRNA and the primary screen pool value ( Supplementary Fig. 1c, left) , which argued that the strongest siRNA largely recapitulates the screen phenotype. This also means that the averaged second and third hit can provide a second independent test for off-target effects ( Supplementary Fig. 1c, right) . The resulting rank-ordered list of deconvolution scores was at the end manually pruned (removing high-scoring genes with functions probably unrelated or indirectly related to mTOR signalling, such as secreted or extracellular proteins, and adding a few lower-scoring genes with relevant functional characteristics) to generate a total of 427 deconvolution hits that we further investigated. mTOR translocation screen. The 427 hits were then assayed for their effect on mTOR translocation. The single siRNA with the strongest phospho-rpS6 phenotype for each hit (see 'Deconvolution of siRNA pools' above) was tested in duplicate in 96-well format at a concentration of 5 nM and assayed in parallel on a single plate for phospho-rpS6. Cells were reverse transfected using the same conditions as the primary screen, except both the transfection and the assay were performed manually using multichannel pipettes. Cells were starved of amino acids for 4 h in 1.5% BSA/DPBS and restimulated with cycloheximide for 5 min (mTOR translocation) or 30 min (rpS6 phosphorylation). The plates were fixed and stained with antibodies against mTOR and Lamp2 or phospho-rpS6 (240/244). The correlation coefficient between the intensity of segmented puncta in the mTOR and Lamp2 channels was calculated for each well and averaged across duplicates. A Z-score for mTOR translocation was generated by subtracting the plate median and normalizing the result by the plate s.d. A Z-score for the parallel phospho-rpS6 experiment was generated by subtracting the mean of the negative control wells (scrambled siRNA) and normalizing the result to their s.d. The plate median was not used in this case because all of the genes were expected to perturb phosphorpS6 levels to some extent, having been selected as deconvolution hits in the first place. Hits with a translocation Z-score below −1.8 and rpS6 phosphorylation below −1.6 were considered for further analysis.
Bioinformatics. Ingenuity Systems pathway analysis (www.ingenuity.com) was used to identify enriched pathways and draw networks. The subset of hits solely chosen based on rank selection were uploaded into Ingenuity pathway analysis and the most enriched canonical pathways or diseases were identified. Fisher's exact test was used to calculate a P value.
Cell culture and reagents. Hs68 primary fibroblasts, HeLa cells, MEFs and HEK293T cells were cultured in 10% FBS/DMEM/PSG (Gibco) medium. HAP1 parental and knockout cells generated by CRISPR-Cas9 were purchased from Horizon Discovery and cultured in 10% FBS/IMDM. Lipofectamine 2000, DPBS media used for starvation, 50× essential amino acids and 100× non-essential amino acids were obtained from Life Technologies. BSA, cycloheximide and PMA were from Sigma-Aldrich. Triton X-100 was from Sigma, and 16% formaldehyde was from Ted Pella. n-Octyl-β-d-glucopyranoside was from Affymetrix. GeneSilencer (Genlantis) was used for siRNA and plasmid co-transfection in HeLa cells. Fugene 6 and X-tremeGENE HP (Roche Applied Science) were used for plasmid transfection into HeLa and HEK293T cells. Lipofectamine 2000 was used to transfect DNA or siRNA into Hs68 and HEK293T cells. The MEF2 Nucleofector Kit was purchased from Lonza to electroporate MEFs using the Amaxa Nucleofector. Rapamycin was purchased from Calbiochem. Torin was purchased from Tocris. Amino acid starvation medium (DMEM without amino acids) was purchased from Athena Enzyme Systems as a custom media. DMEM culture media were used as amino acid addback medium. Amino acid starvation experiments in screen and fluorescence recovery after photobleaching (FRAP) experiments were conducted in 1.5% BSA/DPBS and restimulated with an amino acid mixture (1× AA) added to the starvation media. DMEM without amino acids and 10% dialysed FBS was used as starvation media for all other experiments. GPR137B reagents and various mTORC1 reagents. siRNAs against GPR137B were purchased from Dharmacon as four separate duplexes. The sequence with the strongest effect was GGACUAAAGUAUUCCACAA (3′ untranslated region (UTR)); the second strongest was GCAAUAAUGUAGACUGAUA (3′ UTR). siRNAs against LAMTOR2 and LAMTOR3 were purchased from Dharmacon as siGenome Smartpools. cDNAs encoding GPR137 (NM_001170880) and GPR137C (NM_001099652) were purchased from Open Biosystems, now part of GE Healthcare. GPR137B cDNA was obtained from in-house human ORFeome collection. All GPR137, GPR137B and GPR137C fluorescently tagged proteins were cloned by recombining the cDNA into Gateway destination vectors. Wildtype Venus-RagC, RagC-Turquoise and Venus-RagA were generated by cloning human ORFeome cDNA into the Gateway destination vector. The LC3-GFP (plasmid no. 24920), rat Lamp1-mRFP-2×FLAG (plasmid no. 34611) and YPFraptor (plasmid no. 73385) were obtained from Addgene. Lamp1-Turquoise was subcloned from rat Lamp1-mRFP-2×FLAG using Gateway destination vectors. pRK5-haemagglutinin (HA) glutathione S-transferase (GST) RagA 66L (Addgene plasmid no. 19300) and pRK5-HA GST RagA 21L (Addgene plasmid no. 19299) were gifts from D. Sabatini. YFP-RagC T75N, cyan fluorescent protein (CFP)-RagC Q120L and CFP-RagA T21N were gifts from W. D. Heo. NPC1-YFP-2×FLAG was a gift from M. Lopez. GPR137B-3×FLAG and rat Lamp1-3×FLAG were subcloned into pPBbsr2-IRES-blasticidin, and GPR137B-HA was subcloned into the pLVEF1a-IRES puromycin vector using Gibson assembly (New England Biolabs). C1-mRuby-RagC was generated from Gibson assembly using C1-YFP and mRuby-T-Plastin and subcloned into a Gateway destination vector with wild-type RagC. Infrared fluorescent protein (iRFP)-CAAX was generated by PCR of iRFP with primers encoding the CAAX sequence and entry into pLenti-IRES-Puro and also the Clonetech C1 vector. HEK293T cells stably expressing GPR137B-3×FLAG and Lamp1-3×FLAG were generated using the PiggyBac transposon system (System Biosciences). A GPR137B-HA stable cell line was generated by lentivirus infection. Positive clones were selected using indicated antibiotics.
Fixed/live-cell imaging. High-resolution images (Figs. 1d and 2b,c,e) were acquired on a scanning confocal system (Leica SP2-AOBS) using a ×40 1.25 NA oil immersion objective. Lower-resolution images (Figs. 2g,l, 3a,b,d and 6b,e and Supplementary Figs. 2f and 3a) were acquired on a fully automated fluorescence microscope (ImageXpress Micro XL, Molecular Devices) with a Sola Light Engine (Lumencor), a Zyla 5.5 sCMOS camera (Andor) and using a ×20 0.45 NA Plan Fluor objective (Nikon) with no binning. A ×4 0.13 (NA) objective with no binning was used for Fig. 1b . FRAP images, plasma membrane translocation images and LysoTracker green images (Figs. 6g, 7a,b and 8a and Supplementary Fig. 7a,b) were acquired on an automated widefield/Yokogawa spinning-disc confocal fluorescence microscope system (Intelligent Imaging Innovations, 3i), using either a Nikon ×40 1.3 NA oil objective or a ×100 1.4 NA oil objective, a 3i laser stack (405, 442, 488, 514, 561 and 640 nm), a 3i 'Vector' photomanipulation device, an epifluorescence light source (Sutter Lambda XL), a Yokogawa CSU-W1 scanning head with dual camera port and two sCMOS cameras (Andor Zyla 4.2). These experiments were performed inside an environmental chamber (Haison). FRAP experiments (Fig. 6g-l) were either carried out using a ×40 oil objective at 2 × 2 binning with an epifluorescence light source or a ×100 oil objective at 2 × 2 binning ( Supplementary  Fig. 6e) . A 515-nm laser was used for photobleaching and images were acquired at 10 s per frame in CFP and YFP EPI channels after photobleaching. Plasma membrane translocation images (Fig. 7a,b and Supplementary Fig. 7a,b) were acquired in confocal mode using a ×100 oil objective at 2 × 2 binning and 514-nm, 561-nm and 640-nm lasers. LysoTracker green images (Fig. 8a) were acquired using a ×40 oil objective and 405-nm and 488-nm lasers.
Analysis of lysosomal localization of mTOR. Fluorescence imaging of mTOR translocation was based on immunostaining using anti-mTOR and antiLamp2 antibodies. For screening analysis of the 427 genes, a custom-written MATLAB script was used to cross-correlate the mTOR and Lamp2 signals in a perinuclear region as a measure for relative colocalization (Figs. 1e and 2d) . A more quantitative mTOR localization and translocation parameter (a slower but more automated analysis) was developed for the remainder of the figures (See Supplementary Code 1) . In this analysis, we identified local Lamp2-positive vesicles and created a binary lysosome mask. We used this mask to subtract a local background for the analysis of mTOR localization and translocation. More specifically, the analysis started by first segmenting nuclei and calculating a distance matrix of the closest cytoplasmic pixels to the nucleus. We used a ring identified by >8 pixels and <20 pixels away from the nucleus as the perinuclear region where we identified Lamp2-positive vesicles and measured mTOR intensity at these Lamp2-positive sites. The binary mask of Lamp2 puncta was identified by finding the peak intensity values after subtracting the non-lysosomal background. This Lamp2 puncta segmentation was then used to measure the relative intensity of pixels in the mTOR channel above background. As the lysosomal regions are a small fraction of the area, we used a shifted mask (several pixels shifted in different directions) to measure and subtract a randomized background to detect a lysosomal mTOR intensity over the averaged background value. The mTOR pixel values in the Lamp2 puncta per cell were averaged to derive a 'relative translocation score' for that cell (Fig. 2f, Supplementary Fig. 2b ,c and the remainder of the figures). To quantify the levels of RagA, RagC and Lamp1 at the lysosome (Fig. 6a-f) , we substituted RagA, RagC and Lamp1 for mTOR staining and used an identical automated analysis. For each experiment, 12-25 sites per 96 well were imaged, and at least 1,000 cells were analysed per well and 2-4 wells were included per independent experiment. Statistical analysis was performed either by comparing the averages of control versus treated wells over independent experiments (Figs. 2f,h,j, 3c-e, 4e,f, 6a,d,k,m, 7c and 8b-e,i,j and Supplementary Figs. 1e , 2a-d,h,j, 4e,g and 6e, f) or comparing the averages of transfected cells versus that of non-transfected cells in the same well (Figs. 2k and 4d and Supplementary  Figs. 2h,i and 4f,h) . Parametric, two-tailed Student's t-test and one-way analysis of variance (ANOVA) followed by Tukey's test were used as indicated in the figure legends.
Synergy heatmap analysis of Rag and GPR137B. For Fig. 5c , HeLa cells were amino acid starved for 10-12 h, and cells co-expressing Lamp1-Turquoise and Venus-RagC (n = 14,004) or GPR137B-Turquoise and Venus-RagC (n = 14,207) were binned into 10 equal bins of Turquoise intensities and Venus intensities. The average mTOR translocation score for each bin is plotted as a blue-yellow heatmap scaled from 50 to 450. Grey indicates bins where there was an insufficient number of cells. For Fig. 5e , Rraga/b −/− MEFs transiently co-expressing either Lamp1-Venus with wild-type HA-RagA/Turquoise-RagC (n = 40,061) or DN HARagA/CFP-RagC (T21L/Q120L) (n = 32,958), or GPR137B-Venus with wild-type HA-RagA/Turquoise-RagC (n = 37,520) or DN RagA/CFP-RagC (n = 38,902). We first corrected for fluorophore differences between Turquoise and CFP before generating the heatmaps. We correlated RagA protein levels to RagC fluorescence intensities in the same cell and then normalized DN RagC intensity values by the ratio of the correlation slopes to adjust them to reflect the same amount of RagA proteins at the same wild-type RagC intensities. We plotted all of the singlecell measurements for Rag intensity, Lamp1 or GPR137B intensity and mTOR translocation score and selected a range that represented most values in the histograms. RagC and Lamp1 or GPR137B fluorescence intensities were binned into 10 equal bins, and the average mTOR translocation score of each bin is plotted as a blue-yellow heatmap scaled from 0 to 200. Identical correction and analysis were used for a repeat of this experiment in Supplementary Fig. 6b . n = 31,157 for Lamp1 and wild-type RagA/C, and n = 201,168 for GPR137B and wild-type RagA/C in Supplementary Fig. 6b .
FRAP experiments and analysis. All photobleaching experiments were conducted on the 3i imaging system using a ×40 or ×100 objective ( Supplementary Fig. 6e,f) . Images were acquired every 10 s and bleaching was set to the sixth frame. Bleaching was set in 515 nm for 1 s one time in a rectangular area. For fluorescence recovery measurements, selected lysosomes were tracked manually in ImageJ using Lamp1-Turquoise or GPR137B-Turquoise as a lysosome mask and the corresponding average RagC intensity was recorded for each frame. A background region containing no cells was first subtracted from the raw intensities and then divided by a neighbouring non-bleached region. All values were then normalized to the frame immediately before bleaching (fifth frame). For bar graphs in Fig. 6k ,m, we derived a single measurement by subtracting the fluorescence intensity at frame ten from frame five to represent the relative recovery for each recovery curve, and then averaging the relative recovery for all curves.
Transfection and starvation of HEK293T cells for co-immunoprecipitation.
One day prior to DNA transfection, cells were plated on collagen-coated dishes. The next day, GPR137B was transfected using Lipofectamine 2000 (Thermo Fisher Scientific) in Opti-MEM1 (Thermo Fisher Scientific) overnight. Media were changed to 10% FBS containing DMEM (Thermo Fisher Scientific). Cells were harvested 48 h after transfection. For all co-immunoprecipitation experiments, cells were starved and added back for amino acids in DMEM supplemented with dialysed FBS. When phosphorylation of S6K was examined (Fig. 2m) , DMEM without FBS was used.
Cell lysis and immunoprecipitation. For amino acid-regulated binding, cells were amino acid starved for 2 h and then amino acids were added back for 10-15 min. Cells were incubated with 1 mg ml −1 Dithiobis (succinimidyl propionate) (DSP) for 20 min at room temperature and then the reaction was quenched by treating cells with 100 mM Tris, pH 8.5, for 10 min. Cells were lysed in octyl-glucoside lysis buffer (60 mM n-octyl-β-d-glucopyranoside, 50 mM HEPES (pH 7.4), 150 mM NaCl and protease inhibitor cocktail (Thermo Fisher Scientific) and then homogenized with a 25-G needle and centrifuged at 1,100g at 4 °C for 5 min to remove nuclei. SDS (0.1%) was added to the supernatant. The lysate was sonicated briefly and then incubated at 4 °C for 1 h followed by centrifugation at 20,000g for 60 min. The lysates were adjusted to a total protein concentration of 0.1-0.2 mg ml −1 and incubated with the FLAG-M2 affinity gel (catalogue no. 8823, Sigma) or mouse anti-HA (catalogue no. 88837, lot no. QJ224632, Pierce) at 4 °C overnight. The beads were washed three times with ice-cold lysis buffer with 300 mM NaCl and then washed twice with lysis buffer. Immunoprecipitated proteins were denatured in urea-containing SDS sample buffer (final concentration of 62.5 mM Tris-HCl, 12.5% glycerol, 0.01% bromophenol, 300 mM dithiothreitol, 4 M urea and 3% SDS) at 37 °C for 30 min with rotation. The samples were loaded on 4-12% NuPAGE Bis-Tris, 3-8% Tris-acetate precast gels or Bolt 4-12% Bis-Tris plus gels (Life technologies). The signal intensities were analysed by ImageJ (NIH) and graphed using Prism (GraphPad).
GPR137B-FLAG and GPR137B-HA co-immunoprecipitation. To observe amino acid-sensitive GPR137B-GPR137B self-interaction, GPR137B-FLAG and GPR137B-HA were stably co-expressed in Rraga/b −/− MEFs or control MEFs at low levels. To achieve this, the upstream open reading frames of pPBbsr2-GPR137b-FLAG and pLV-EF1a-GPR137B-HA were attenuated by adding a TTT sequence 61 .
Only earlier passages of cells were used.
MEFs were amino acid starved for 3-4 h, restimulated for 20 min and then DSP crosslinked. The GPR137B complex was immunoprecipitated using a FLAG-M2 affinity gel at 4 °C overnight. The complex was analysed by western blot.
TALEN and CRISPR targeting to generate mutations in zebrafish gpr137b
homologues. The TAL Effector-Nucleotide Targeter 2.0 (refs. 62, 63 ) webtool was used to design a pair of TALENs to target gpr137c, gpr137 and gpr137ba. The Golden Gate cloning protocol for creating the TALEN plasmids was used 64 . Plasmids were then transcribed using the Sp6 mMessage mMachine Kit by Ambion. mRNA (400 ng) were injected into one-cell-stage wild-type TL embryos, which were raised to adulthood. To identify founders carrying a null mutation in the germline, we crossed injected fish to the wild type (TL strain) and genotyped a subset of the progeny at 2-3 d post-fertilization (dpf). The TALEN lesions were given the following names and genotyped using the following primers and restriction assays: gpr137c, st117, 10-bp deletion, forward primer: ttggataagtcggcgtgatag, reverse primer: cgtcctcagagcagaccag, restriction assay using DpnII; gpr137, st118, 8-bp deletion, forward primer: ccatgagcgtcattttcctg, reverse primer: acacccgaatgcatcacac, restriction assay using HpaI; gpr137ba, st119, 20-bp deletion, forward primer: gagcagtgggaagcagaaac, reverse primer: ggtaacgcaaaaccaaccac, restriction assay using SfaNI. All restriction enzymes cleave the wild-type allele, but not the mutant allele. Based on the disruption of the restriction site, we identified founders and raised the remaining F1 progeny to adulthood. F1 heterozygous adults for the respective deletions were crossed to the TL strain to establish a stock.
For CRISPR experiments, sgRNAs were designed using CHOPCHOP. The sgRNA was transcribed from the DNA template with T7 polymerase (E2040S, New England Biolabs) and purified using the mirVana miRNA isolation kit (AM1560, Ambion). Cas9 protein (Macrolab, Berkeley) and ~300 ng sgRNA were injected into one-cell-stage embryos, and embryos were genotyped to detect lesions. The sgRNA used for gpr137bb was GGGTCACTACCGGTTGTACC. The efficacy of the sgRNA was determined by sequencing eight individual embryos after PCR using forward primer: GCTATTCCCAGCCACGTGTTC and reverse primer: CACAGGAGATACAGCTCAGTGC.
LysoTracker red and neutral red staining of live zebrafish larvae. Larvae (not selected for gender) at 4 dpf were incubated in a 1:100 dilution of LysoTracker red DND-99 (Invitrogen) in embryo water at 28.5 °C for 45 min, washed twice with embryo water, mounted in 1.5% LMP agarose and imaged with a Zeiss confocal microscope. For the neutral red assay, larvae at 5 dpf (not selected for gender) were incubated in 2.5 μg ml −1 neutral red at 28.5 °C for 2.5 h, washed twice with embryo water, mounted in 1.5% LMP agarose and analysed using a dissecting microscope.
Particle analysis in ImageJ. LysoTracker red-stained images were thresholded to generate a binary image and despeckled. ' Analyze particles' with a setting of area of >30 pixels was used to generate overlays and measure the area of LysoTracker redstained punctae. ; gpr137ba +/− female adults. At 5 dpf, larvae (not selected for gender) were anaesthetized with tricaine. DNA was prepared from tail fins of individual fish, and the remaining portion of each fish was snap frozen on dry ice. The genotypes of each animal were determined by a PCR assay for the gpr137ba lesion and the frozen larvae were pooled based on the genotype for gpr137ba. Three batches of 15-16 embryos that were either heterozygous (gpr137ba
) mutants were pooled separately to obtain biological triplicates. Total RNA was extracted from pooled embryos using the RNAeasy Kit (Qiagen). cDNA was synthesized using iScript Supermix (1708840, Bio-Rad). Quantitative PCR was performed with SsoAdvancedTM Universal SYBR Green Supermix (1725271, Bio-Rad) on the Bio-Rad CFX384 Real-Time PCR Detection System. All experiments were done in biological and technical triplicates. Transcript levels were normalized to eif1a 25, 65 . Relative mRNA levels were calculated using ΔΔ CT.
Statistics and reproducibility. Unpaired, parametric, two-tailed Student's t-tests were performed using Prism (GraphPad) to analyse the statistical significance of experiments in Figs. 2f,h,k, 3d, 4e,f, 6m and 7c and Supplementary Figs. 1e,  2c ,e,h-j and 6f. Paired, parametric, two-tailed Student's t-tests were used for experiments in Fig. 6d,k and Supplementary Figs. 2e,g and 4h , and ratio paired ttests were applied to Figs. 2j, 6a and 8b,c and Supplementary Fig. 2d ,i. For multiple group comparisons, one-way ANOVA was performed using GraphPad for Fig. 3c and Supplementary Fig. 2b , and repeated-measures ANOVA was used for Figs. 4d and 8d,e and Supplementary Fig. 4f . All ANOVA analyses were followed by Tukey's test. Unpaired, parametric, two-tailed t-test with Welch's correction was used for the fish experiments in Fig. 8g,i,j. A description of each statistical test and P values are included with each experimental source data (Supplementary Table 4) . Experiments in Figs. 2l,m, 3e, 4a-c and 5e and Supplementary Figs. 1a, 3b, 4a,b,d , 5a and 7a were performed two times independently showing similar results. The experiment in Supplementary Fig. 7b was done once. All other experiments were performed three or more times independently showing similar results.
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
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Field-collected samples
The study did not involve samples collected from the field.
Ethics oversight
Stanford University Institutional Animal Care and Use Committee approved the zebrafish protocol.
Note that full information on the approval of the study protocol must also be provided in the manuscript.
Human research participants
Policy information about studies involving human research participants 
Ethics oversight
Identify the organization(s) that approved the study protocol.
Clinical data Policy information about clinical studies
All manuscripts should comply with the ICMJE guidelines for publication of clinical research and a completed CONSORT checklist must be included with all submissions.
Clinical trial registration
Provide the trial registration number from ClinicalTrials.gov or an equivalent agency.
Study protocol
Note where the full trial protocol can be accessed OR if not available, explain why.
Data collection
Describe the settings and locales of data collection, noting the time periods of recruitment and data collection.
Outcomes
Describe how you pre-defined primary and secondary outcome measures and how you assessed these measures.
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Data deposition
Confirm that both raw and final processed data have been deposited in a public database such as GEO.
Confirm that you have deposited or provided access to graph files (e.g. BED files) for the called peaks. 
Data access links
Flow Cytometry Plots
Confirm that:
The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
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Methodology Sample preparation
Describe the sample preparation, detailing the biological source of the cells and any tissue processing steps used.
Instrument
Identify the instrument used for data collection, specifying make and model number. 
Gating strategy
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Magnetic resonance imaging Experimental design
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